| 1 | 2016年国际抗癫痫联盟癫痫发作分类的更新及介绍显示文摘国际抗癫痫联盟(ILAE)提出了癫痫发作类型的操作性修订方案。此修订的目的包括认识到一些发作类型既可以是局灶起源亦可以为全面起源,允许临床在不能观察到发作起源的情况下进行发作分类,纳入某些尚不了解的发作类型,以及采用更加易懂的命名。由于现有知识不足以形成一个科学的分类方案,2016年的分类方案是在1981年和2010年分类的基础上进行的操作性(实用性)修订。新分类的变化包括:(1)'部分性'改为'局灶性';(2)起源未知的癫痫发作也可以归类;(3)知觉状态用作局灶性发作的区分因素;(4)删除'认知障碍性'、'简单部分性'、'复杂部分性'、'精神性'、'继发全面性'等术语;(5)认识到局灶性强直、阵挛、失张力、肌阵挛和癫痫性痉挛发作,这些发作也有双侧性类型;(6)增加了新的全面性发作类型:伴眼睑肌阵挛的失神发作,肌阵挛失神发作,肌阵挛-失张力发作,阵挛-强直-阵挛发作,癫痫性痉挛;癫痫性痉挛可以是局灶性、全面性或起源不明性;(7)双侧强直阵挛发作取代了继发全面性发作。新的分类方案并未进行根本性的改变,但可以使癫痫发作类型的命名有较大的灵活性和透明度。 | Robert S Fisher J Helen Cross 陈佳 王玉平 吴逊 | 2017 | 癫痫杂志2017，3，1： | 25 |
| 2 | Vein transplantation using human umbilical cord blood stem cells in the treatment of stroke sequela显示文摘BACKGROUND: Transplanted mononuclear cell(MNC)of umbilical blood can survive in central nervous system (CNS)of host through blood brain barrier,differentiate into nerver cells,migrate to damaged site and integrate morphological strucgh and function with nerve cells of host so as to improve deficiencies of sensatory function,motor function and cognitive function and influence on stroke sequela.OBJECTIVE: To observe the vein transplantation of human umbilical cord blood stem cells(HUCBSC) for improving neurological function,limb funtion and activity of daily living of patients with stroke and evaluate the reliability.DESIGN: Self-controlled study.SETTING: Department of Neurosurgery,the Second People's Hospital of Zhengzhou City;Red-crossed Blood Center of Henan Province;Department of Neurosurgery,the Fist Affiliated Hospital of Zhenzhou University.PARTICIPANTS:A total of 10 patients with stoke sequela were selected from Department of Cerebral Surgery,the Second People's Hospital of Zhengzhou City from April to December 2005.There were 9males and 1 female aged from 35to 75years with the mean age of 56 years.All of them were diagnosed with CT and MRI examination and coincidence with diagnostic criteria of stroke established by the Fourth National Academic Meeting for Cerebrovascular Disease.All patients provided informed consent. METHODS:80-140 mL umbilical blood of term birth of newborn was selected hermetically and maintained in sterile plastic bag.And then,the blood was centrifugated at the speed of 1500 r/min for 30 minutes at 22℃ in order to separate MNC,i.e.,HUCBSC.In addition,after final diagnosis during hospitalization,stroke patients were perfused with HUCBSC through superficial vein of back of the hand.Each patient was averagely penfused with 6 portions of HUCBSC(cellular numbers≥1×108/portion)and the interval between each portion was 1-7 days with the mean interval of 4 days.MAIN OUTCOME MEASURES: ①Neurological function of stroke patients was evaluated with neurological function deficiency(NFD)before treatment and at 3 months after treatment.The scale includes consciousness,level fix function.facial paralysis,language,muscle force of upper limbs,muscle force of lower limb and step function.The total scores ranged from 0 to 45; meanwhile,the lower the scores were,the better the neurological function of limbs was. ②Motor function of injured limbs was evaluated with Fugl-Meyer Assessment (FMA),including motor function of upper limbs.motor function of lower limbs,balance ability,sensory function and motion of joint.The total scores ranged from 0 to 226;meanwhile,the higher the scores were,the better the motor function of limbs was.③Activities of daily living(ADL)was evaluated with Barthel Index(BI),including having meals,taking a bath,dressing oneself,putting on clothes,walking in balance and stair activity.The total scores ranged from 0 to 100;meanwhile,the higher the scores were,the stronger the ADL was.RESULTS:A total of 10 patients were involved in the final analysis.After treatment,NFD of stroke patients was (10.9±5.09)points,which was lower than that before treatment[(25.4±6.09)points,t=8.213,P<0.01].In addition,after treatment,FMA and BI of stroke patients were(80.9±25.00)points and(81.1±15.93)points,re spectively,which were higher than those before treatment[(31.9+21.85)points,(36.2+19.41)points,t=13.024,13.670,P<0.01]. Immuno-suppressive drugs were not used during the whole therapeutic procedure;moreover,immunological rejection and allergic reaction were not observed during the same period.CONCLUSION:Transplanting HUCBSC through superficial vein of back of the hand is regarded as a simple and safe method for the treatment of stroke sequela. | Yong Man1, Jianbin Li2, Bo Yang3, Ji Ma1 1Department of Cerebral Surgery, the Second People’s Hospital of Zhengzhou, Zhengzhou 450000, Henan Province, China 2Red Cross Blood Center of Henan Province, Zhengzhou 450000, Henan Province, China 3Department of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China | 2006 | Neural Regeneration Research2006，1，7： | 7 |
您所在的机构暂未开通此部分的功能，请联系管理员